NCT07151547

Brief Summary

Purpose of the Study: The aim of this study is to determine the cut-off values of gait variability and limits of stability-postural sways scores in patients with MS in order to identify fall risk at an early stage and take necessary precautions. Additionally, the study aims to compare the effectiveness of these parameters in distinguishing between fallers and non-fallers. The study includes four hypotheses: H₁: Gait variability scores can differentiate between fallers and non-fallers in patients with MS. H₂: Limits of stability and postural sways scores can differentiate between fallers and non-fallers in patients with MS. H₃: Gait variability scores provide higher sensitivity and specificity than stability limits and postural sway scores in distinguishing between fallers and non-fallers in patients with MS. H₄: Limits of stability and postural sways scores provide higher sensitivity and specificity than gait variability scores in distinguishing between fallers and non-fallers in patients with MS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 17, 2025

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

August 6, 2025

Completed
28 days until next milestone

First Posted

Study publicly available on registry

September 3, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 6, 2026

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

May 22, 2026

Status Verified

May 1, 2026

Enrollment Period

6 months

First QC Date

August 6, 2025

Last Update Submit

May 20, 2026

Conditions

Keywords

cut-offfallsgait variabilitylimits of stabilitypostural swaysmultiple sclerosis

Outcome Measures

Primary Outcomes (4)

  • Limits of Stability

    Limits of stability assessment will be conducted using the Bertec Balance Check Screener™ force platform system (45×45 cm, 13 cm thick), which detects body movements via foot pressure.Limits of stability will be measured by asking participants to lean maximally in four directions (forward, backward, right, left) without losing balance. Stability scores (in cm and %) will be calculated using Balance Check Software.

    up to 5 months

  • Postural sways

    Postural sways assessment will be conducted using the Bertec Balance Check Screener™ force platform system (45×45 cm, 13 cm thick), which detects body movements via foot pressure. A foam pad of the same size is used to assess postural sway. Postural sways will be evaluated under four conditions (eyes open/closed on firm/foam surfaces). Participants will stand still for 10 seconds per condition, repeated three times. The average stability score (%) will be recorded for each condition.

    up to 5 months

  • Gait variability

    Gait variability will be performed using the GAITRite® system, a 4.6-meter portable walkway mat embedded with pressure sensors that record step data without interfering with the natural gait. Participants will walk naturally across the mat three times; the average of the trials will be analyzed. Gait variability will be expressed as the coefficient of variation (CV) (%). Using this formula: CV (%) = (standard deviation/mean) × 100.

    up to 5 months

  • Fall Histories

    The following fall-related information will be recorded: Number of Falls Cause of Fall Time of Fall Activity During Which the Fall Occurred Type of Fall Fall-Related Injury / If Present, Type of Injury

    up to 5 months

Study Arms (1)

Multiple Sclerosis

• Patients diagnosed with MS by a neurologist according to the McDonald criteria, aged 18 years or older, having an EDSS score of ≤ 5 (able to walk independently), and having a Mini-Mental State Examination score of 24 or higher will be included in the study.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

MS patients with the inclusion criteria

You may qualify if:

  • Diagnosed with MS by a neurologist according to the McDonald criteria
  • Aged 18 years or older
  • EDSS ≤ 5 (able to walk independently)
  • Mini-Mental State Examination score of 24 or higher

You may not qualify if:

  • Patients with neurological conditions other than MS that may affect independent walking or standing, those with lower extremity pain, or a history of lower extremity fractures within the past 6 months
  • Patients who do not agree to participate or do not provide written informed consent will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University

Ankara, Altındağ, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Muhammed Kılınç

    Hacettepe University

    PRINCIPAL INVESTIGATOR
  • Ender Ayvat

    Hacettepe University

    PRINCIPAL INVESTIGATOR
  • Fatma Ayvat

    Hacettepe University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 6, 2025

First Posted

September 3, 2025

Study Start

July 17, 2025

Primary Completion

January 6, 2026

Study Completion

January 31, 2026

Last Updated

May 22, 2026

Record last verified: 2026-05

Locations